返回 Agenda
LS01 Future Directions Based on Experience Developing Drugs to Treat Novel Coronavirus Infections
Session Chair(s)
Kanji Hirai, RPh
Director, Regulatory Policy & Intelligence, Regulatory Affair Area, Japan Dvlpmt
MSD K.K., Japan
Speaker(s)
Hiroko Kawaguchi
MSD Japan, Japan
Associate Director, Regulatory Affairs
Hirofumi Sone
Pfizer R&D Japan, Japan
Manager, Japan Regulatory Lead, Regulatory Affairs
Yuji Arakawa
Ministry of Health, Labour and Welfare (MHLW), Japan